# CagriSema REDEFINE 1: BMI and waist-to-height targets

Source: https://pepvault.app/research/cagrilintide-redefine-1-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Cagrilintide](https://pepvault.app/research#cagrilintide)

Randomized trial · people

# CagriSema: 30.3% hit both BMI and waist-to-height targets at 68 weeks

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this trial, more people on CagriSema reached set BMI and waist-to-height goals than on semaglutide, cagrilintide alone or placebo, and those goals may be a useful way to track progress beyond the number on the scale.

- **Kind:** Randomized trial
- **Studied in:** People
- **Published:** 2026
- **Journal:** Diabetes Obes Metab

## What they tested

The team asked whether body-size targets, BMI and waist-to-height ratio, add useful information beyond percentage weight loss when judging obesity treatment.

## How the study was done

A secondary, post hoc look at REDEFINE 1, a 68-week phase 3a randomized trial in adults without diabetes who had a BMI of 30 kg/m2 or more, or 27 kg/m2 or more plus at least 1 obesity-related health problem. Once a week, people received the CagriSema combination (2.4 mg of each drug), semaglutide alone at 2.4 mg, cagrilintide alone at 2.4 mg, or placebo (a dummy treatment), each alongside lifestyle changes.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking cagrilintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At week 68, the share of people who reached both a BMI under 27 kg/m2 and a waist-to-height ratio (WHtR) under 0.53 was 30.3% with CagriSema, 19.1% with semaglutide, 9.0% with cagrilintide alone and 3.3% with placebo. BMI and WHtR worked about equally well as markers for reaching or keeping healthy levels in four heart and metabolic measures: blood sugar, blood pressure, triglycerides (a blood fat) and HDL cholesterol. When stricter cutoffs were used, the body-size targets tracked these outcomes better than percentage weight loss did.

## What it doesn’t show

This was a post hoc analysis, meaning the questions were asked after the trial was done, so it shows links rather than proof that hitting a target causes better health. It only included adults without diabetes.

## The paper

Busetto et al. Efficacy of CagriSema for Reaching Anthropometric Treatment Targets and Cardiometabolic Outcomes: A Secondary, Post hoc Analysis of REDEFINE 1. Diabetes Obes Metab. 2026.

- [PubMed (PMID 42503495)](https://pubmed.ncbi.nlm.nih.gov/42503495/)
- [The paper (DOI 10.1111/dom.71134)](https://doi.org/10.1111/dom.71134)

## The compounds

- [Cagrilintide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/cagrilintide)
- [CagriSema: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/cagrisema)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)
- [CagriSema dose guide](https://pepvault.app/lab/dosage/cagrisema)

## With this study

### Cagrilintide

- [Cagrilintide: the full reference](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)

### CagriSema

- [CagriSema: the full reference](https://pepvault.app/peptides/cagrisema)
- [CagriSema dose guide](https://pepvault.app/lab/dosage/cagrisema)

### Mixing charts

- [Cagrilintide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-5mg)
- [Cagrilintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-10mg)

### Studies

- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 7 studies](https://pepvault.app/research#cagrilintide)
- [All 4 studies](https://pepvault.app/research#cagrisema)

### Compared with

- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)
- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Cagrilintide vs Petrelintide](https://pepvault.app/peptides/compare/cagrilintide-vs-petrelintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Post hoc analysis](https://pepvault.app/glossary/post-hoc-analysis)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## More studies on Cagrilintide

- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026) Randomized trial · people · 2026
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026) Randomized trial · people · 2026
- [Cagrilintide-semaglutide: 20.4% weight loss at 68 weeks in REDEFINE 1](https://pepvault.app/research/cagrilintide-redefine-1-2025) Randomized trial · people · 2025
- [CagriSema: 13.7% weight loss at 68 weeks in REDEFINE 2](https://pepvault.app/research/cagrisema-redefine-2-2025) Randomized trial · people · 2025
- [Cagrilintide with semaglutide: 15.6% weight loss in type 2 diabetes](https://pepvault.app/research/cagrilintide-frias-2023) Randomized trial · people · 2023
- [Cagrilintide with semaglutide: 17.1% weight loss at 2.4 mg, week 20](https://pepvault.app/research/cagrilintide-enebo-2021) Randomized trial · people · 2021
- [Every study on Cagrilintide](https://pepvault.app/research#cagrilintide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cagrilintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking cagrilintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Cagrilintide

- [Cagrilintide: the full reference](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)

### CagriSema

- [CagriSema: the full reference](https://pepvault.app/peptides/cagrisema)
- [CagriSema dose guide](https://pepvault.app/lab/dosage/cagrisema)

### Mixing charts

- [Cagrilintide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-5mg)
- [Cagrilintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-10mg)

### Studies

- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 7 studies](https://pepvault.app/research#cagrilintide)
- [All 4 studies](https://pepvault.app/research#cagrisema)

### Compared with

- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)
- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Cagrilintide vs Petrelintide](https://pepvault.app/peptides/compare/cagrilintide-vs-petrelintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Post hoc analysis](https://pepvault.app/glossary/post-hoc-analysis)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Taking cagrilintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Cagrilintide](https://pepvault.app/research#cagrilintide)

## The library

- [Cagrilintide](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)
- [CagriSema](https://pepvault.app/peptides/cagrisema)
- [CagriSema dose guide](https://pepvault.app/lab/dosage/cagrisema)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
